Date: 2013-10-16
Type of information: Development agreement
Compound: ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories
Company: Sartorius Stedim Biotech (Germany - France) BD Diagnostics (USA)
Therapeutic area: Technology - Services
Type agreement: development
production
commercialisation
Action mechanism:
Disease:
Details: * On October 16, 2013, Sartorius Stedim Biotech (SSB), an international pharma and biotech supplier, and BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a global medical technology company, have announced a collaboration to develop, manufacture and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories.
Based on its many years of expertise in the development of membranes, SSB offers high-quality, single-use filter products for concentration of microbial contaminants in the lab. As part of this strategic collaboration, BD will fill special SSB single-use products with BD culture media and supply these to SSB as prepackaged products. In addition, the companies are exploring options of extending their existing business relationship by pursuing further innovative solutions in the field of microbiological diagnostics.
Financial terms:
Latest news:
